Carry Pledge to EndFA / CureFA / Friedreichs Ataxia Research Alliance
FA is an inherited neurodegenerative disorder, causing progressive loss of muscle coordination and strength. It's caused by a genetic mutation in the FXN gene, leading to a deficiency in the protein frataxin, which is vital for energy production in cells.
Symptoms (beginning in childhood or adolescence) include difficulty walking, impaired balance, loss of sensation in the limbs, slurred speech and fatigue.
FA research might inform the treatment of other genetic diseases through advances in induced pluripotent stem cell (iPSC) technology, which allows for the development of disease-specific cell models for various repeat expansion disorders like Huntington's disease and other spinocerebellar ataxias.
Thomas Brenninkmeijer, a friend of FCP has recently founded and committed significantly to EndFA (UK).
PARTNERSHIP WITH FCP
FCP’s partners have committed future carried interest to EndFa.
